Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4528)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 24, 2023 (publication date) through Jul 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rocha Pinheiro SL, Lemos FFB, Marques HS, Silva Luz M, de Oliveira Silva LG, Faria Souza Mendes dos Santos C, da Costa Evangelista K, Calmon MS, Sande Loureiro M, Freire de Melo F. Immunotherapy in glioblastoma treatment: Current state and future prospects. World J Clin Oncol 2023; 14(4): 138-159 [PMID: 37124134 DOI: 10.5306/wjco.v14.i4.138] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i4/138.htm |
| Number | Citing Articles |
| 1 |
Anna Galicka, Łukasz Szoka, Iwona Radziejewska, Cezary Marcinkiewicz. Effect of Dimeric Disintegrins Isolated from Vipera lebetina obtusa Venom on Glioblastoma Cellular Responses. Cancers 2023; 15(19): 4805 doi: 10.3390/cancers15194805
|
| 2 |
Pooya Farhangnia, Hossein Khorramdelazad, Pouria Ghiaee, Soheil Rahmani Fard, Ali-Akbar Delbandi. . Interdisciplinary Cancer Research 2023; doi: 10.1007/16833_2023_186
|
| 3 |
Jan Patrick Formanski, Hai Dang Ngo, Vivien Grunwald, Celine Pöhlking, Jana Sue Jonas, Dominik Wohlers, Birco Schwalbe, Michael Schreiber. Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1gfp and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures. Cancers 2024; 16(4): 814 doi: 10.3390/cancers16040814
|
| 4 |
Augusto Müller Fiedler, Michelle Medeiros, Haidi Dalinda Fiedler. Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo–Engineered Transferrin-Like Peptides: Protocol for a Novel Method. JMIR Research Protocols 2023; 12: e49417 doi: 10.2196/49417
|
| 5 |
Krishna Malhotra. Predictions of Viral-Immunotherapy Glioblastoma Patient Response and Progression using Deep Neural Networks Reveal Novel Biomarkers for Targeted Therapy. SSRN Electronic Journal 2024; doi: 10.2139/ssrn.4854377
|
| 6 |
Hao Zhang, Ying Hong, Tingting Wu, Eyi Ben, Shuai Li, Liu Hu, Tao Xie. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1401967
|
| 7 |
Santino Caserta, Sebastiano Gangemi, Giuseppe Murdaca, Alessandro Allegra. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. International Journal of Molecular Sciences 2023; 24(14): 11544 doi: 10.3390/ijms241411544
|
| 8 |
Wenya He, Ningyang Wang, Yaping Wang, Mengyao Liu, Qian Qing, Qihang Su, Yan Zou, Yang Liu. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma. Pharmaceutics 2024; 16(4): 482 doi: 10.3390/pharmaceutics16040482
|
| 9 |
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, Lorenzo Colarossi, Angela Prestifilippo, Gabriele Pizzino, Irene Paterniti, Emanuela Esposito, Anna Paola Capra. Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma. Cells 2024; 13(4): 361 doi: 10.3390/cells13040361
|
| 10 |
Pablo Shimaoka Chagas, Henrique Izumi Shimaoka Chagas, Sahar Emami Naeini, Bidhan Bhandari, Jules Gouron, Tathiane M. Malta, Évila Lopes Salles, Lei P. Wang, Jack C. Yu, Babak Baban. Network‐Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma. Journal of Cellular Biochemistry 2024; doi: 10.1002/jcb.30612
|
| 11 |
Sophie A. Dusoswa, Jan Verhoeff, Saskia van Asten, Joyce Lübbers, Marlous van den Braber, Sophie Peters, Sanne Abeln, Matheus H.W. Crommentuijn, Pieter Wesseling, William Peter Vandertop, Jos W. R. Twisk, Thomas Würdinger, David Noske, Yvette van Kooyk, Juan J. Garcia-Vallejo. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1343484
|
| 12 |
Lisa Feldman. Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1384249
|
| 13 |
Lauren Michelle Webb, Mason J. Webb, Jian L. Campian, Samantha J. Caron, Michael W. Ruff, Joon H. Uhm, Ugur Sener. A case series of osseous metastases in patients with glioblastoma. Medicine 2024; 103(27): e38794 doi: 10.1097/MD.0000000000038794
|
| 14 |
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Gutiérrez-Arroyo, Alba Loras, Luis Gonzalez-Bonet, Conrado Martinez-Cadenas, José Estrela, María Marqués-Torrejón. Glioblastoma Therapy: Past, Present and Future. International Journal of Molecular Sciences 2024; 25(5): 2529 doi: 10.3390/ijms25052529
|
| 15 |
Sehar Ul Duaa, Eeshal Fatima, Zaheer Qureshi. Pamiparib, A Novel Intervention with Anti-neoplastic Activity for the Treatment of Glioblastoma. The American Journal of the Medical Sciences 2024; doi: 10.1016/j.amjms.2024.07.007
|
| 16 |
Nina Nelson, Angela Relógio. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock. npj Precision Oncology 2024; 8(1) doi: 10.1038/s41698-024-00530-z
|
| 17 |
Mervenur Yavuz, Turan Demircan. Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy. Toxicology and Applied Pharmacology 2024; 490: 117029 doi: 10.1016/j.taap.2024.117029
|
| 18 |
Prateek Jain, Shambhavi Vashist, Binay K Panjiyar. Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression. Cureus 2023; doi: 10.7759/cureus.46089
|
| 19 |
In Kang, Yumin Kim, Heung Kyu Lee. γδ T cells as a potential therapeutic agent for glioblastoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1273986
|
| 20 |
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, Aleksandra Zacny, Tomasz Lorenc, Wioletta Olejarz. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. International Journal of Molecular Sciences 2024; 25(11): 5774 doi: 10.3390/ijms25115774
|
| 21 |
Garima Yadav, Ritu Kulshreshtha. Pan-cancer analyses identify MIR210HG overexpression, epigenetic regulation and oncogenic role in human tumors and its interaction with the tumor microenvironment. Life Sciences 2024; 339: 122438 doi: 10.1016/j.lfs.2024.122438
|
| 22 |
Tanner M. Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata, Joshua L. Dowling, Michael R. Chicoine, Ralph G. Dacey, Gregory J. Zipfel, Albert H. Kim, Elaine R. Mardis, Gavin P. Dunn. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research 2024; 30(13): 2729 doi: 10.1158/1078-0432.CCR-23-3077
|